| Spread of Cryptococcus gattii into Pacific Northwest region of the United States K Datta, KH Bartlett, R Baer, E Byrnes, E Galanis, J Heitman, L Hoang, ... Emerging infectious diseases 15 (8), 1185, 2009 | 317 | 2009 |
| Species-specific Prevalence of Vaginal Candidiasis Among Patients with Diabetes Mellitus and its Relation to their Glycaemic Status R Goswami, V Dadhwal, S Tejaswi, K Datta, A Paul, RN Haricharan, ... Journal of Infection 41 (2), 162-166, 2000 | 210 | 2000 |
| Aspergillosis Complicating Severe Coronavirus Disease KA Marr, A Platt, JA Tornheim, SX Zhang, K Datta, C Cardozo, ... Emerging infectious diseases 27 (1), 2020 | 187 | 2020 |
| The absence of serum IgM enhances the susceptibility of mice to pulmonary challenge with Cryptococcus neoformans KS Subramaniam, K Datta, E Quintero, C Manix, MS Marks, L Pirofski The Journal of Immunology 184 (10), 5755-5767, 2010 | 123 | 2010 |
| Cystic fibrosis transmembrane conductance regulator regulates epithelial cell response to Aspergillus and resultant pulmonary inflammation N Chaudhary, K Datta, FB Askin, JF Staab, KA Marr American journal of respiratory and critical care medicine 185 (3), 301-310, 2012 | 98 | 2012 |
| Immunogenicity and Efficacy of Cryptococcus neoformans Capsular Polysaccharide Glucuronoxylomannan Peptide Mimotope-Protein Conjugates in Human … RW Maitta, K Datta, A Lees, SS Belouski, L Pirofski Infection and immunity 72 (1), 196-208, 2004 | 92 | 2004 |
| A multicenter, longitudinal cohort study of cryptococcosis in human immunodeficiency virus–negative people in the United States KA Marr, Y Sun, A Spec, N Lu, A Panackal, J Bennett, P Pappas, ... Clinical Infectious Diseases 70 (2), 252-261, 2020 | 84 | 2020 |
| Cryptococcosis in India: the awakening of a giant? U Banerjee, K Datta, T Majumdar, K Gupta Sabouraudia 39 (1), 51-67, 2001 | 82 | 2001 |
| Fluconazole and itraconazole susceptibility of clinical isolates of Cryptococcus neoformans at a tertiary care centre in India: a need for care K Datta, N Jain, S Sethi, A Rattan, A Casadevall, U Banerjee Journal of Antimicrobial Chemotherapy 52 (4), 683-686, 2003 | 78 | 2003 |
| Protective and Nonprotective Human Immunoglobulin M Monoclonal Antibodies to Cryptococcus neoformans Glucuronoxylomannan Manifest Different Specificities … RW Maitta, K Datta, Q Chang, RX Luo, B Witover, K Subramaniam, ... Infection and immunity 72 (8), 4810-4818, 2004 | 73 | 2004 |
| Cryptococcus gattii: Emergence in Western North America: Exploitation of a Novel Ecological Niche K Datta, KH Bartlett, KA Marr Interdisciplinary Perspectives on Infectious Diseases, 176532, 2009 | 72 | 2009 |
| Detection of urinary excreted fungal galactomannan-like antigens for diagnosis of invasive aspergillosis SF Dufresne, K Datta, X Li, E Dadachova, JF Staab, TF Patterson, ... Public Library of Science 7 (8), e42736, 2012 | 69 | 2012 |
| Towards a vaccine for Cryptococcus neoformans: principles and caveats K Datta, L Pirofski FEMS yeast research 6 (4), 525-536, 2006 | 68 | 2006 |
| Therapeutic efficacy of a conjugate vaccine containing a peptide mimotope of cryptococcal capsular polysaccharide glucuronoxylomannan K Datta, A Lees, L Pirofski Clinical and Vaccine Immunology 15 (8), 1176-1187, 2008 | 54 | 2008 |
| Urine Antigen Detection as an Aid to Diagnose Invasive Aspergillosis KA Marr, K Datta, S Mehta, DB Ostrander, M Rock, J Francis, ... Clinical Infectious Diseases 67 (11), 1705-1711, 2018 | 52 | 2018 |
| Niche-specific requirement for hyphal wall protein 1 in virulence of Candida albicans JF Staab, K Datta, P Rhee PloS one 8 (11), e80842, 2013 | 46 | 2013 |
| Isavuconazole activity against Aspergillus lentulus, Neosartorya udagawae, and Cryptococcus gattii, emerging fungal pathogens with reduced azole susceptibility K Datta, P Rhee, E Byrnes III, G Garcia-Effron, DS Perlin, JF Staab, ... Journal of clinical microbiology 51 (9), 3090-3093, 2013 | 43 | 2013 |
| Serotype distribution of Cryptococcus neoformans in patients in a tertiary care center in India U Banerjee, K Datta, A Casadevall Medical Mycology 42 (2), 181-186, 2004 | 43 | 2004 |
| Cryptococcus gattii Infection in Healthy Hosts: A Sentinel for Subclinical Immunodeficiency? KA Marr, K Datta, L Pirofski, R Barnes Clinical infectious diseases 54 (1), 153-154, 2012 | 37 | 2012 |
| Development and evaluation of a fully automated molecular assay targeting the mitochondrial small subunit rRNA gene for the detection of Pneumocystis jirovecii in … B Liu, M Totten, S Nematollahi, K Datta, W Memon, S Marimuthu, LA Wolf, ... The Journal of Molecular Diagnostics 22 (12), 1482-1493, 2020 | 32 | 2020 |
Sean X. ZhangThe Johns Hopkins Hospital在 jhmi.edu 的电子邮件经过验证
